Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXR6B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,618
Award facts
- Contract value 100% obligated
- $21,618.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,618.12 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 23, 2026. This firm fixed-price, competitively awarded contract (with no set-aside designation) is scheduled for completion by January 26, 2026, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Dupixent (dupilumab) is a biologic medication used to treat conditions such as atopic dermatitis, asthma, and other inflammatory diseases, demonstrating the critical nature of specialized pharmaceutical products delivered through this strategic contracting vehicle.
Quick answers
Who was awarded contract SPE2DR26FXR6B?
SPE2DR26FXR6B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FXR6B worth?
The government has obligated $21,618 on SPE2DR26FXR6B.
Is contract SPE2DR26FXR6B an order under another contract?
Yes. SPE2DR26FXR6B is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR6B competed?
The extent of competition for SPE2DR26FXR6B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award